effects compared to chemical medicines. Many antidiabetic products of herbal origin are available in India. Hence, we planned to evaluate effect of one of them, that is, fenugreek (Trigonella foenumgraecum). These seeds have been shown to have an effect on cholesterol and blood sugar. [1] Fenugreek seeds are used for the treatment of diabetes mellitus (DM) in many parts of the world including India. [2-4] These seeds are high in soluble fibers, saponins, trigonelline, diosgenin, and 4-hydroxy leucine. [5,6] Soluble fibers like galactomannan help in lowering blood sugar by slowing down digestion and absorption of carbohydrates. Saponins form large mixed micelles with bile salts and significantly reduce cholesterol by increasing fecal excretion of bile salts, thereby inhibiting Background: Fenugreek is an aromatic plant widely grown worldwide. Two fairly distinct types of plants are recognizedthe dwarf type grown for culinary purposes and the tall type grown for medicinal purposes. It has small round leaves sold as vegetables (fresh leaves, sprouts) commonly known as methi and long pods that contained seeds known as menthe, which are used as such or in powdered form. These seeds are rich in soluble fibers and many phytochemical compounds. In addition to its hypoglycemic effect, the hypolipidemic effect of fenugreek seeds has also been documented. Therefore, fenugreek seeds have a dual role in the management of diabetes. It has been used as a herbal medicine in the management of glycemia and dyslipidemia since a long time in India. Objective: To evaluate the effect of fenugreek seeds taken orally in patients with type 2 diabetes mellitus (DM) with dyslipidemia. Materials and Methods: This prospective study was conducted on patients with type 2 DM with dyslipidemia after meeting inclusion and exclusion criteria. The patients were divided into two groups (age matched). One group received fenugreek seeds and other group received drugs (oral hypoglycemic and hypolipidemic agents). Lipid profile and HbA 1 C were measured initially as well as after 8 weeks of treatment period. Blood sugar (fasting) was recorded weekly. Student's t-test was applied for statistical analysis. Results: After 8 weeks of treatment of fenugreek seeds in group 1 patients, there was a significant improvement in blood glucose Fasting level (178±72.4 to 104±28.2; p < 0.0001), T-cholesterol (350±20.6 to 176±17.2; p < 0.0001), triglycerides (280±18.2 to 132±16.8; p < 0.0001), low-density cholesterol (220±21.4 to 96±14.2; p < 0.0001), and high-density cholesterol (27.0±13.4 to 58±32.2; p < 0.0002). Although there was an improvement in HbA 1 C status but it was not significant. Conclusion: This study supports beneficial effects of fenugreek seeds on glycemia and dyslipidemia in patients with type 2 DM and can be used as an adjuvant/alternative in management of diabetes and its complications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.